Wambolt & Associates’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
Wambolt & Associates's MRK Position: Q2 2025 in Review
Wambolt & Associates opened a new position in Merck (MRK) in Q2 2025: 3,146 shares worth $257K. The stake represents 0.09% of the portfolio and ranks #159 among its holdings. This is a return to the name: Wambolt & Associates previously reported a position in MRK as recently as Q4 2024.
Wambolt & Associates first reported a position in MRK in Q4 2019 and has held it in 22 quarters since. The position peaked at $582K in Q4 2023. 3,328 funds tracked by Wall St. Rank hold MRK as of Q2 2025.
- Wambolt & Associates held 3,146 shares of Merck worth $257K as of Q2 2025.
- Merck was a new Wambolt & Associates position in Q2 2025.
- Merck made up 0.09% of Wambolt & Associates's portfolio in Q2 2025, its #159 holding.
- Wambolt & Associates first reported a position in Merck in Q4 2019 and has held it in 22 quarters since.
- Wambolt & Associates's Merck position peaked at $582K in Q4 2023.
- 3,328 funds tracked by Wall St. Rank held Merck as of Q2 2025.
Based on Wambolt & Associates's 13F filing for Q2 2025, filed 13 Aug 2025.